The mechanism behind masseter muscle pain, a major symptom of temporomandibular disorder (TMD), has remained poorly understood. Previous report indicates that adenosine triphosphate (ATP) in involved in the masseter muscle pain development, but the role of its hydrolysis product, adenosine diphosphate (ADP), remains uncertain. Consequently, this study aimed to elucidate the ADP role derived from the sustained masseter muscle contraction in the masseter muscle pain development. The right masseter muscle was electrically stimulated daily by placing electrodes on the muscle fascia, inducing strong contraction and mechanical allodynia. This led to an increment of the ATP release from the masseter muscle and a consequent increase in ADP produced by the hydrolysis of ATP. The mechanical allodynia was suppressed by intramuscular P2Y receptor antagonism and tumor necrosis factor alpha (TNF-α) inhibition. Additionally, muscle satellite cells expressed P2Y receptors, and the increase in amount of TNF-α released from these cells due to sustained contraction of the masseter muscle was suppressed by intramuscular P2Y receptor antagonism. These findings suggest that sustained masseter muscle contraction increases ADP levels within the muscle; this ADP, produced by the hydrolysis of ATP via P2Y receptors, promotes the release of TNF-α. The TNF-α signaling is likely to enhance the excitability of primary neurons projecting to the masseter muscle, thereby inducing masseter muscle pain. Therefore, it is plausible that TNF-α-induced nociceptive neuronal hyperexcitability through enhanced ADP signaling via P2Y receptors in satellite cells could be a candidate for therapeutic intervention for masseter muscle pain, a major symptom of TMD. PERSPECTIVE: Sustained masseter muscle contraction in rats induced mechanical allodynia and increased the amount of ADP within the muscle. Muscle satellite cells expressed P2Y receptors, and ADP-P2Y signaling increased the TNF-α release from these cells. TNF-α signaling enhanced the primary neuronal excitability, inducing masseter muscle pain.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jpain.2025.105360 | DOI Listing |
J Pain
March 2025
Department of Physiology, Nihon University School of Dentistry, Tokyo, Japan. Electronic address:
The mechanism behind masseter muscle pain, a major symptom of temporomandibular disorder (TMD), has remained poorly understood. Previous report indicates that adenosine triphosphate (ATP) in involved in the masseter muscle pain development, but the role of its hydrolysis product, adenosine diphosphate (ADP), remains uncertain. Consequently, this study aimed to elucidate the ADP role derived from the sustained masseter muscle contraction in the masseter muscle pain development.
View Article and Find Full Text PDFArch Oral Biol
March 2025
Department of Biomorphology, Institute of Health Sciences, Federal University of Bahia, Salvador, BA, Brazil. Electronic address:
Objective: Previous studies have shown that botulinum toxin type A (BoNT-A) attenuates nociception, but the underlying mechanisms remain unclear. Studies of experimental pain in humans have also shown conflicting results. Carrageenan is commonly used to produce short-term acute inflammation and hyperalgesia in animal models, and the effect of BoNT-A on carrageenan-induced pain in the masseter muscle has not been studied.
View Article and Find Full Text PDFObjective: Pulsed radiofrequency (PRF) combined with low-temperature continuous radiofrequency (CRF) might be a novel technique for relieving trigeminal neuralgia (TN). This study aimed to evaluate the efficacy and safety of high-voltage PRF combined with low-temperature CRF in primary TN.
Methods: This randomized controlled trial was performed between December 2, 2020, and October 26, 2022.
Semin Arthritis Rheum
February 2025
Department of Rheumatology, St Vincent's Hospital Melbourne, 41 Victoria Parade, Fitzroy, VIC 3065 Australia; Department of Medicine, The University of Melbourne, Parkville, VIC 3052, Australia. Electronic address:
Aims: Systemic sclerosis (SSc) affects skeletal muscle directly, with SSc-associated myopathy (SSc-myopathy) increasingly recognised as a distinct immune-mediated myopathy. Manual muscle testing and creatine kinase (CK) are insensitive diagnostic tools for SSc-myopathy. We aimed to evaluate the role of imaging in SSc-myopathy diagnosis.
View Article and Find Full Text PDFDent Med Probl
March 2025
Department of Dental Medicine, Fattouma Bourguiba University Hospital, Monastir, Tunisia.
Botulinum toxin type A (BTX-A) injections have emerged as a promising alternative for the management of bruxism. In this context, a systematic review of randomized controlled trials on the impact of BTX-A on patients with bruxism was conducted. A literature search of multiple online electronic databases (PubMed®, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials (CENTRAL)) was undertaken from their inception to February 1, 2024.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!